BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23362849)

  • 1. VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement.
    Demir HD; Ortak H; Şahin Ş; Ateş Ö; Benli I; İnanır A
    Ophthalmic Genet; 2014 Mar; 35(1):7-11. PubMed ID: 23362849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intron F G79A polymorphism of the protein Z gene in Turkish Behçet patients.
    Demir HD; Yalçındağ FN; Oztürk A; Akar N
    Curr Eye Res; 2012 Jul; 37(7):630-2. PubMed ID: 22559296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.
    Ortak H; Söğüt E; Demir H; Ardagil A; Benli I; Sahin S
    Clin Exp Ophthalmol; 2012; 40(7):743-8. PubMed ID: 22394334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-1639A but Not C1173T
    Dubovyk YI; Harbuzova VY; Ataman AV
    Biomed Res Int; 2016; 2016():1298198. PubMed ID: 27703968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-8 Gene Polymorphisms in Behçet's Disease Observed in Denizli Province of Turkey.
    Atalay A; Arıkan S; Ozturk O; Öncü M; Tasli ML; Duygulu S; Atalay EO
    Immunol Invest; 2016 May; 45(4):298-311. PubMed ID: 27101127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 gene polymorphism in Turkish patients with Behçet's disease and its association with ocular involvement.
    Yücel A; Dilek K; Saba D; Ozçimen AA; Yurtkuran M; Oral HB
    Int J Immunogenet; 2013 Oct; 40(5):349-55. PubMed ID: 23331481
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Osman NA; El-Abd N; Nasrallah M
    Saudi J Kidney Dis Transpl; 2016; 27(5):908-915. PubMed ID: 27751997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.
    El Din MS; Amin DG; Ragab SB; Ashour EE; Mohamed MH; Mohamed AM
    Int J Lab Hematol; 2012 Oct; 34(5):517-24. PubMed ID: 22533669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of PTPN22 polymorphisms with susceptibility to ocular Behcet's disease in two Chinese Han populations.
    Zhang Q; Hou S; Jiang Z; Du L; Li F; Xiao X; Kijlstra A; Yang P
    PLoS One; 2012; 7(3):e31230. PubMed ID: 22396730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of NFKB1 and NFKBIA polymorphisms in relation to susceptibility of Behçet's disease.
    Yenmis G; Oner T; Cam C; Koc A; Kucuk OS; Yakicier MC; Dizman D; Kanigur Sultuybek G
    Scand J Immunol; 2015 Jan; 81(1):81-6. PubMed ID: 25367031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
    Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
    Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
    Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
    Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet's disease.
    Talaat RM; Ashour ME; Bassyouni IH; Raouf AA
    Immunobiology; 2014 Aug; 219(8):573-82. PubMed ID: 24703990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin.
    Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ
    J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Vitamin K Epoxide Reductase (VKORC1) -1639G>A Polymorphism and Osteoporosis in Postmenopausal Women.
    Kutluturk F; Inanir A; Rustemoglu A; Kaya SU; Demir AK; Dursun G; Yigit S
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):281-286. PubMed ID: 29437025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K epoxide reductase complex 1 (VKORC1) gene polymorphisms in population of Eastern Croatia.
    Mandić D; Mandić S; Horvat V; Samardzija M; Samardzija M
    Coll Antropol; 2013 Dec; 37(4):1321-6. PubMed ID: 24611351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.
    Holzer G; Grasse AV; Zehetmayer S; Bencur P; Bieglmayer C; Mannhalter C
    Transl Res; 2010 Jul; 156(1):37-44. PubMed ID: 20621035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behçet's disease with or without ocular involvement.
    Dursun A; Durakbasi-Dursun HG; Dursun R; Baris S; Akduman L
    Inflamm Res; 2009 Jul; 58(7):401-5. PubMed ID: 19255721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the NOS3 gene in Tunisian patients with Behçet's disease.
    Kallel A; Sbaï MH; Houman MH; Sediri Y; Ouertani D; Smiti Khanfir M; Ben Ghorbel I; Jemaa R; Kaabachi N
    Int J Immunogenet; 2015 Apr; 42(2):87-92. PubMed ID: 25639851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.